Lexeo Therapeutics Inc. Insider Trading
LXEO
Insiders sold 739K and bought nothing on the open market.
42% of the selling was scheduled in advance under 10b5-1 plans. Chief Medical Officer Narinder Pal Bhalla sold 99K on Jul 1, 21% of their stake, outside a plan. The last open-market buy by an executive or director was in Nov 2024.
Get an email when LXEO's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17 | Louis Edward Tamayo Chief Financial Officer | SoldNo plan | 1,007 | $3.26 | 3K | 1.1% | Form 4 |
| Nov 17 | Jose Manuel Otero Chief Operating Officer | SoldNo plan | 1,285 | $3.26 | 4K | 0.9% | Form 4 |
| Nov 17 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 3,295 | $3.26 | 11K | 0.9% | Form 4 |
| Aug 18 | Louis Edward Tamayo Chief Financial Officer | SoldNo plan | 4,117 | $4.91 | 20K | 4.2% | Form 4 |
| Aug 18 | Jose Manuel Otero Chief Operating Officer | SoldNo plan | 1,304 | $4.96 | 6K | 0.9% | Form 4 |
| Aug 18 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 3,345 | $4.95 | 17K | 0.9% | Form 4 |
| Jul 1 | Narinder Pal Bhalla Chief Medical Officer | SoldNo plan | 22,306 | $4.42 | 99K | 21% | Form 4 |
| Jul 1 | Louis Edward Tamayo Chief Financial Officer | SoldNo plan | 4,641 | $4.49 | 21K | 4.6% | Form 4 |
| Jul 1 | Jose Manuel Otero Chief Operating Officer | SoldNo plan | 4,666 | $4.48 | 21K | 3.3% | Form 4 |
| Jul 1 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 25,947 | $4.48 | 116K | 6.4% | Form 4 |
| May 18 | Jose Manuel Otero Chief Operating Officer | SoldNo plan | 1,302 | $5.07 | 7K | 1.0% | Form 4 |
| May 18 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 3,342 | $5.06 | 17K | 1.0% | Form 4 |
| Apr 6 | Richard Nolan Townsend Chief Executive Officer | Sold10b5-1 plan | 55,000 | $5.69 | 313K | 14% | Form 4 |
| Feb 18 | Jose Manuel Otero Chief Operating Officer | SoldNo plan | 3,016 | $6.40 | 19K | 2.3% | Form 4 |
| Feb 18 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 10,173 | $6.38 | 65K | 2.5% | Form 4 |
| Nov 18, 2025 | Jose Manuel Otero Chief Operating Officer | SoldNo plan | 721 | $9.27 | 7K | 1.1% | Form 4 |
| Nov 18, 2025 | Tai Sandi See Chief Development Officer | SoldNo plan | 386 | $9.27 | 4K | 0.6% | Form 4 |
| Nov 18, 2025 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 1,127 | $9.27 | 10K | 0.5% | Form 4 |
| Nov 18, 2025 | Jenny Robertson Chief Legal Officer | SoldNo plan | 549 | $9.27 | 5K | 0.8% | Form 4 |
| Nov 18, 2025 | Eric Adler Chief Medical Officer | SoldNo plan | 615 | $9.27 | 6K | 0.8% | Form 4 |
| Oct 17, 2025 | Jose Manuel Otero Chief Technical Officer | SoldNo plan 2 parts | 2,115 | $8.95 average | 19K | 3.2% | Form 4 |
| Oct 17, 2025 | Tai Sandi See Chief Development Officer | SoldNo plan 2 parts | 3,888 | $8.95 average | 35K | 5.6% | Form 4 |
| Oct 17, 2025 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan 2 parts | 13,133 | $8.95 average | 118K | 5.1% | Form 4 |
| Oct 17, 2025 | Jenny Robertson Chief Legal Officer | SoldNo plan 2 parts | 3,526 | $8.95 average | 32K | 4.9% | Form 4 |
| Oct 17, 2025 | Eric Adler Chief Medical Officer | SoldNo plan 2 parts | 3,382 | $8.95 average | 30K | 4.4% | Form 4 |
| Aug 18, 2025 | Jose Manuel Otero Chief Technical Officer | SoldNo plan | 721 | $9.27 | 7K | 1.1% | Form 4 |
| Aug 18, 2025 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 1,115 | $4.67 | 5K | 0.5% | Form 4 |
| Aug 18, 2025 | Jose Manuel Otero Chief Technical Officer | SoldNo plan | 2,848 | $4.67 | 13K | 4.5% | Form 4 |
| Aug 18, 2025 | Jenny Robertson Chief Legal Officer | SoldNo plan | 542 | $4.67 | 3K | 0.9% | Form 4 |
| Aug 18, 2025 | Eric Adler Chief Medical Officer | SoldNo plan | 608 | $4.67 | 3K | 0.9% | Form 4 |
| Aug 18, 2025 | Tai Sandi See Chief Development Officer | SoldNo plan | 382 | $4.67 | 2K | 0.6% | Form 4 |
| May 16, 2025 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 1,074 | $2.77 | 3K | 0.5% | Form 4 |
| May 16, 2025 | Eric Adler Chief Medical Officer | SoldNo plan | 585 | $2.77 | 2K | 0.9% | Form 4 |
| May 16, 2025 | Jenny Robertson Chief Legal Officer | SoldNo plan | 521 | $2.77 | 1K | 0.8% | Form 4 |
| May 16, 2025 | Tai Sandi See Chief Development Officer | SoldNo plan | 367 | $2.77 | 1K | 0.6% | Form 4 |
| Feb 19, 2025 | Richard Nolan Townsend Chief Executive Officer | SoldNo plan | 4,326 | $4.41 | 19K | 1.9% | Form 4 |
| Feb 19, 2025 | Tai Sandi See Chief Development Officer | SoldNo plan | 1,486 | $4.41 | 7K | 2.7% | Form 4 |
| Feb 19, 2025 | Eric Adler Chief Medical Officer | SoldNo plan | 2,359 | $4.41 | 10K | 3.3% | Form 4 |
| Feb 19, 2025 | Jenny Robertson Chief Legal Officer | SoldNo plan | 2,101 | $4.41 | 9K | 3.5% | Form 4 |
| Dec 10, 2024 | Richard Nolan Townsend Chief Executive Officer | Sold10b5-1 plan | 2,500 | $8.20 | 21K | 2.0% | Form 4 |
- Nov 17No planLouis Edward TamayoChief Financial Officer · sold 1,007 at $3.263K1.1% of stake
- Nov 17No planJose Manuel OteroChief Operating Officer · sold 1,285 at $3.264K0.9% of stake
- Nov 17No planRichard Nolan TownsendChief Executive Officer · sold 3,295 at $3.2611K0.9% of stake
- Aug 18No planLouis Edward TamayoChief Financial Officer · sold 4,117 at $4.9120K4.2% of stake
- Aug 18No planJose Manuel OteroChief Operating Officer · sold 1,304 at $4.966K0.9% of stake
- Aug 18No planRichard Nolan TownsendChief Executive Officer · sold 3,345 at $4.9517K0.9% of stake
- Jul 1No planNarinder Pal BhallaChief Medical Officer · sold 22,306 at $4.4299K21% of stake
- Jul 1No planLouis Edward TamayoChief Financial Officer · sold 4,641 at $4.4921K4.6% of stake
- Jul 1No planJose Manuel OteroChief Operating Officer · sold 4,666 at $4.4821K3.3% of stake
- Jul 1No planRichard Nolan TownsendChief Executive Officer · sold 25,947 at $4.48116K6.4% of stake
- May 18No planJose Manuel OteroChief Operating Officer · sold 1,302 at $5.077K1.0% of stake
- May 18No planRichard Nolan TownsendChief Executive Officer · sold 3,342 at $5.0617K1.0% of stake
- Apr 610b5-1 planRichard Nolan TownsendChief Executive Officer · sold 55,000 at $5.69313K14% of stake
- Feb 18No planJose Manuel OteroChief Operating Officer · sold 3,016 at $6.4019K2.3% of stake
- Feb 18No planRichard Nolan TownsendChief Executive Officer · sold 10,173 at $6.3865K2.5% of stake
- Nov 18, 2025No planJose Manuel OteroChief Operating Officer · sold 721 at $9.277K1.1% of stake
- Nov 18, 2025No planTai Sandi SeeChief Development Officer · sold 386 at $9.274K0.6% of stake
- Nov 18, 2025No planRichard Nolan TownsendChief Executive Officer · sold 1,127 at $9.2710K0.5% of stake
- Nov 18, 2025No planJenny RobertsonChief Legal Officer · sold 549 at $9.275K0.8% of stake
- Nov 18, 2025No planEric AdlerChief Medical Officer · sold 615 at $9.276K0.8% of stake
- Oct 17, 2025No planJose Manuel OteroChief Technical Officer · sold 2,115 at avg $8.9519K3.2% of stake
- Oct 17, 2025No planTai Sandi SeeChief Development Officer · sold 3,888 at avg $8.9535K5.6% of stake
- Oct 17, 2025No planRichard Nolan TownsendChief Executive Officer · sold 13,133 at avg $8.95118K5.1% of stake
- Oct 17, 2025No planJenny RobertsonChief Legal Officer · sold 3,526 at avg $8.9532K4.9% of stake
- Oct 17, 2025No planEric AdlerChief Medical Officer · sold 3,382 at avg $8.9530K4.4% of stake
- Aug 18, 2025No planJose Manuel OteroChief Technical Officer · sold 721 at $9.277K1.1% of stake
- Aug 18, 2025No planRichard Nolan TownsendChief Executive Officer · sold 1,115 at $4.675K0.5% of stake
- Aug 18, 2025No planJose Manuel OteroChief Technical Officer · sold 2,848 at $4.6713K4.5% of stake
- Aug 18, 2025No planJenny RobertsonChief Legal Officer · sold 542 at $4.673K0.9% of stake
- Aug 18, 2025No planEric AdlerChief Medical Officer · sold 608 at $4.673K0.9% of stake
- Aug 18, 2025No planTai Sandi SeeChief Development Officer · sold 382 at $4.672K0.6% of stake
- May 16, 2025No planRichard Nolan TownsendChief Executive Officer · sold 1,074 at $2.773K0.5% of stake
- May 16, 2025No planEric AdlerChief Medical Officer · sold 585 at $2.772K0.9% of stake
- May 16, 2025No planJenny RobertsonChief Legal Officer · sold 521 at $2.771K0.8% of stake
- May 16, 2025No planTai Sandi SeeChief Development Officer · sold 367 at $2.771K0.6% of stake
- Feb 19, 2025No planRichard Nolan TownsendChief Executive Officer · sold 4,326 at $4.4119K1.9% of stake
- Feb 19, 2025No planTai Sandi SeeChief Development Officer · sold 1,486 at $4.417K2.7% of stake
- Feb 19, 2025No planEric AdlerChief Medical Officer · sold 2,359 at $4.4110K3.3% of stake
- Feb 19, 2025No planJenny RobertsonChief Legal Officer · sold 2,101 at $4.419K3.5% of stake
- Dec 10, 202410b5-1 planRichard Nolan TownsendChief Executive Officer · sold 2,500 at $8.2021K2.0% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with LXEO
Held by ETFs
LXEO is in 14 US ETFs. The largest of them, with LXEO's weight in each:
iShares Russell 2000 Value ETFIWN0.01%of the fund
State Street SPDR S&P Biotech ETFXBI0.05%of the fund
iShares Biotechnology ETFIBB0.01%of the fund
Fidelity Enhanced Small Cap ETFFESM0.01%of the fund
State Street SPDR S&P Kensho New Economies Composite ETFKOMP0.07%of the fund
iShares Micro-Cap ETFIWC0.05%of the fund
Spot a number that looks wrong? Check it in LXEO's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LXEO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.